Cerebral palsy is a dubious disease in the field of the nervous system, with complex clinical outcomes that often involve multi-system congestion. Early identification and standardised clinical care are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical outcomes, imaging inspections, laboratory tests and pathological tests.
The platform can assist in connecting national and international teams of authoritative experts to provide accurate diagnosis and treatment programs. Individual development of treatment programs for treatment and management of Cerebral palsy is required, which typically includes pharmacotherapy, rehabilitation, and regular follow-up. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many formerly difficult-to-treat neurological disorders have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adjusted in a timely manner according to changes in the disease. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of cerebral palsy. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment programs; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of changes in conditions and treatment effects.